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Abstract
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protective efficacy of BCG
against TB is better for children than for adults. One potential explanation is that BCG induces a better protective immune
response in children. Twenty six children and adults were immunised with BCG. The proportion of Th1-cytokine-producing
mycobacterial-specific T cells, and the concentrations of secreted cytokines, were measured before and 10 weeks after BCG
immunisation. A significant increase in the proportion of mycobacterial-specific cytokine-producing T cells was observed in
both age groups. After BCG immunisation, children and adults had comparable proportions of mycobacterial-specific
polyfunctional CD4 T cells when measured relative to the total number of CD4 T cells. However, relative to the subset of Th-
1-cytokine-producing CD4 T cells, the proportion of polyfunctional cells was greater in children. Concentrations of secreted
cytokines were comparable in children and adults. These findings suggest that the mycobacterial-specific cell-mediated
immune response induced by BCG immunisation in children and adults is similar. The implication of a shift to a more
polyfunctional immune response within the Th1-cytokine-producing CD4 T cells in children is uncertain as this aspect of the
immune response has not been assessed as a potential correlate of protection against TB.
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Introduction
Bacille-Calmette-Gue´rin (BCG) is one of the most commonly
administered vaccines worldwide with more than 100 million
doses given each year. Studies investigating the protective efficacy
of BCG against tuberculosis (TB) suggest protective efficacy is
better for children than for adults [1,2]. One potential explanation
is that BCG induces a better protective immune response in
children. Although there is evidence that age at immunisation
influences the immune response to BCG, the two most recent
studies addressing this issue compared the immune response in
different age groups both in the first year of life [3,4]. Only one
previous study, from the Gambia, has compared the immune
response in BCG-immunised children and adults [5]. However, in
this study the adults had been BCG immunised many years earlier
whereas the children had been immunised only two months prior
to assessment. Consequently, in the adult group, waning immunity
or intervening exposure to Mycobacterium tuberculosis may have
influenced the results. Therefore, currently available data do not
answer the question whether there is a difference in the immune
response between BCG-immunised adults and children when
measured at a similar time interval after immunisation in both age
groups.
A number of studies in either children or adults have
investigated the complex immune response induced by BCG-
immunisation. In children, this has most commonly been studied
in infants. Neonatal BCG immunisation has been shown to induce
antigen-specific interferon (IFN)-c-producing CD4 and CD8 T
cells [6,7,8,9,10], proliferation of CD4 [11,12], CD8 [7] and c/d
T cells [10,11], cytotoxicity in CD8 T cells [7,12], secretion of a
variety of cytokines and chemokines [8,9,11,12,13,14,15], and
more recently, the induction of mycobacterial-specific polyfunc-
tional CD4 T cells [10,16]. Polyfunctional CD4 T cells
simultaneously producing IFN-c, interleukin (IL)-2 and tumor
necrosis factor (TNF)-a, or a combination thereof, have recently
attracted attention as potential correlates of protection against TB
[17].
Few studies have investigated the immune response to BCG in
recently-immunised adults. In this age group, BCG has been
shown to induce a mycobacterial-specific IFN-c response
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[18,19,20,21,22], T cell proliferation [18,19,20,21,22] and cyto-
toxicity of CD8 T cells [21,23].
Differences in the immune response induced by BCG between
children and adults might explain the difference in protective
immunity conferred by BCG in these age groups.
Materials and Methods
Ethics Approval
Approval for this study was obtained from the respective human
research ethics committees of the Royal Children’s Hospital and
The University of Melbourne, Australia. Written informed consent
was obtained from parents or participants.
Study Participants and Blood Collection
Healthy children under two years of age, who were to be given
BCG immunisation for intended travel to countries with high TB
incidence, were recruited at the Royal Children’s Hospital
Melbourne. Adult volunteers were recruited from medical students
at the University of Melbourne. After obtaining written informed
consent, intradermal BCG vaccine (BCG-Connaught, Sanofi
Pasteur, Toronto, Canada) was administered in the left deltoid
region by a using a dose of 0.05 ml in children under 12 months of
age and 0.1 ml after the first year of life. A tuberculin skin test
(TST, 5 TU Tubersol, Sanofi Pasteur, Toronto, Canada) was
done before immunisation in individuals over six months of age to
exclude previous M. tuberculosis infection. In the adult volunteers,
an IFN-c release assay (QuantiFERON-TB Gold In-Tube,
Celestis, Carnegie, Australia) was also done. Blood was collected
before, and 10 weeks after BCG immunisation.
Antigens and Antibodies for in vitro Assays
Lyophilised BCG was reconstituted to a concentration of
1006106 CFU/ml by adding sterile water and Roswell Park
Memorial Institute media (Invitrogen, Mulgrave, Victoria, Aus-
tralia) and used at a final concentration of 1.66106 CFU/ml.
Purified protein derivative (PPD, Batch RT50, Statens Serum
Institute, Copenhagen, Denmark) was used at a concentration of
20 mg/ml. Staphylococcal enterotoxin B (SEB, Sigma-Aldrich, St.
Louis, MO, USA) was used at a concentration of 10 mg/ml as a
positive control. Co-stimulatory antibodies anti-CD28 and anti-
CD49d (both from BD Biosciences, San Jose, CA, USA) were used
each at a concentration of 1 mg/ml [24].
Whole Blood Intracellular Cytokine Assay
One ml of heparinised blood was incubated within one hour of
collection with BCG, PPD, SEB or media alone in the presence of
Figure 1. Gating strategy. (A) Selection of populations containing single cell CD4 or CD8 T cells. Each subsequent panel shows only the population
of interest that has been selected from the gate on the previous plot. (B) Selection of CD4 T cells producing the cytokines of interest shown in an
unstimulated and a BCG stimulated sample from one individual. The same gating strategy was used for CD8 T cells (not shown). Boolean gating was
used to calculate proportions of polyfunctional T cells.
doi:10.1371/journal.pone.0037535.g001
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co-stimulatory antibodies CD28 and CD49d at 37uC for 12 hours.
After 7 hours, 200 ml of plasma were removed and cryopreserved,
and Brefeldin A (BfA) (Sigma-Aldrich) was added at a concentra-
tion of 10 mg/ml. After 12 hours samples were cooled to room
temperature and harvested within 10 hours using ethylenedi-
aminetetraacetic acid (EDTA, Sigma-Aldrich) at 2 mM. Cells
were incubated with FACS lysing solution (BD Biosciences) before
cryopreservation at 280uC.
Cell Staining and Flow Cytometric Analysis
Cryopreserved cells were thawed and permeabilised with
Perm2 Solution (BD Biosciences) for 10 minutes. Cells were then
washed with PBS staining buffer containing 0.5% bovine serum
albumin and 0.1% sodium azide before incubation with
fluorochrome-conjugated antibodies for 30 minutes in the dark.
The following conjugated antibodies (all from BD Biosciences)
were used: anti-CD3 PerCP-Cy5.5 (SK7), anti-CD4 FITC (RPA-
T4), anti-CD8 Alexa-700 (RPA-T8), anti-IFN-c PE-Cy7 (4S.B3),
anti- IL-2 PE (MQ1-17H12) and anti-TNF APC (Mab11). The
choice and concentrations of fluorochrome-conjugated antibodies
had been previously optimised. Flow cytometric acquisition was
done on a LSRII flow cytometer (BD Biosciences) with voltages
of photomultiplier tube voltages and settings optimised using
cytometer setup and tracking beads (BD Biosciences). Automated
compensation was calculated with FACSDiva software (version
6.1, BD Biosciences) using anti-mouse and anti-rat Ig kappa
compensation beads. For each sample, a minimum of 100 000
CD3 cells were acquired. Flow cytometric analysis was done
using Flowjo (version 8.8.6, TreeStar Inc, Ashland, OR, USA). A
hierarchical gating strategy was used to select single cell CD4
and CD8 T cell populations (Figure 1 panel A). Gates for
cytokine production from blood stimulated with BCG or PPD
were set using the unstimulated control. A Boolean combination
of gates was used to calculate double- and triple-positive
populations. The mean fluorescence intensity was calculated
using Flowjo software for all subpopulations. For single- and
double-cytokine-producing populations, MFI was analysed only
when more than nine cells per population were detected; for
triple cytokine-producing cells, MFI was analysed for populations
with more than four detected cells.
Cytokine/chemokine Analysis
Cryopreserved supernatants were thawed and analysed using
xMAP technology (Milliplex Human Cytokine Immunoassay,
Millipore Corp., Billerica, MA, USA) for the following cytokines
and chemokines: eotaxin, IL-2, IL-6, IL-10, IL-12 (p40), IL-13,
IFN-c, monocyte chemotactic protein (MCP)-1, macrophage
inflammatory protein (MIP)-1b and TNF-a. Pilot experiments
showed that IL-4, IL-5 and IL-17 were not produced in detectable
concentrations in this assay (data not shown). The manufacturer’s
instructions were followed. The provided standards were used to
generate standard curves. Samples were added undiluted at a
volume of 25 ml for all cytokines and additionally for IL-6, MCP-1,
MIP-1b and TNF-a in 1:20 dilutions. Mixed beads were added
and plates incubated on a plate shaker at room temperature in the
dark for one hour. After washing plates detection antibodies were
added and incubated for 30 minutes followed by another 30
minutes incubation with streptavidin-phycoerythrin solution. The
plate was washed, sheath fluid added analysed on a calibrated
Luminex 200 instrument (Luminex Corp., Austin, TX, USA)
using xPONENT software (version 3.1, Luminex Corp., Austin,
TX, USA). For analysis cytokine/chemokine concentrations were
background-corrected by subtracting the concentrations detected
in the unstimulated sample.
Statistics
For comparison of results before and after BCG immunisation a
Wilcoxon matched pairs test was used. For comparison of results
in children and adults, a Mann-Whitney test was used. For overall
comparisons of MFI a Kruskal-Wallis test was used, and for
comparisons of two populations a Mann-Whitney test was used.
Significance for all correlations were calculated using a Spear-
man’s rank correlations coefficient. Statistics were calculated and
graphs produced using Prism 5 (Graph Pad Software Inc., La
Jolla, CA, USA). A p-value less than 0.05 was considered
significant in the initial analysis, and Bonferroni corrections were
used to account for multiple testing.
Results
Study Participants
Of the 23 children recruited, 13 returned for a second blood
sample after BCG immunisation. Their median age at BCG
immunisation was 9.6 months (range 6 weeks to 2 years) and four
participants were female. Results were negative (,5 mm) for all
TSTs performed. Of the 16 medical students recruited, 13
returned for the second blood sample after BCG immunisation.
Their median age at BCG immunisation was 24.0 years (range
20.7 to 32.4 years) and nine participants were female. Results were
negative for all TSTs (,5 mm) and QuantiFERON-TB Gold In-
Tube assays (TB antigen response minus nil control response
#0.35 IU/ml).
Proportions of Cytokine-producing T cells before and
after BCG Immunisation
In children, the proportions of the seven subpopulations of
BCG-specific CD4 T cells producing IFN-c, IL-2 or TNF-a alone
or simultaneously (ie polyfunctional CD4 T cells) was increased 10
weeks after BCG immunisation (Figure 1 panel B, Figure 2 panel
A and B). In adults, a similar pattern was seen (Figure 3, panel A
and B). Notably, adults had higher proportions of BCG-specific
CD4 T cells before BCG immunisation compared to children. In
both children and adults, the proportion of Th-1 cytokine-
producing BCG-specific CD8 T cells, did not significantly differ 10
weeks after BCG immunisation (Figures 2 and 3, panel C and D).
Similar results were seen in PPD-specific CD4 and CD8 T cells
in both children and adults (data not shown).
Changes in Cytokine-producing T cells in Children
Compared to Adults
The median change in cytokine-producing T cell populations
was calculated for each participant by subtracting the proportions
before BCG immunisation from proportions after BCG immuni-
sation. There was no significant difference between children and
adults in the change in proportions of BCG- and PPD-specific
CD4 T cells (Figure 4, panel A). For CD8 T cells, there was a
greater increase in the proportion of single IFN-c-producing T
cells in adults than in children (Figure 4, panel B). However, this
difference was not statistically significantly.
Next we compared the quality of the immune response in
children and adults by calculating the proportion of single-,
double- or triple-cytokine producing cells within the Th1 cytokine-
producing CD4 T cell population (in contrast to within the total
CD4 T cell population). Following in vitro stimulation with BCG,
the proportion of polyfunctional Th1-cytokine-producing T cells
was significantly higher in children than in adults (Figure 5 panel
A). Following in vitro stimulation with PPD, similar results were
found (Figure 5 panel B).
Immune Response to BCG in Children and Adults
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Cytokine-producing Capacity of T cells
Polyfunctional CD4 T cells showed higher cytokine-producing
capacity in both children and adults. For example, following in vitro
stimulation with BCG, cells producing IFN-c without simulta-
neous production of IL-2 or TNF-a showed lower mean
fluorescence intensity (MFI) for IFN-c than cells producing two
or three of these cytokines simultaneously (Figure 6, panel A). The
same was true for IL-2 and TNF-a.
In children, the median MFI was generally greater in double- and
triple-cytokine-producing compared to single-cytokine-producing
CD4 T cells for IFN-c, IL-2 and TNF-a following in vitro stimulation
with BCG (Figure 6, panel B). Similarly in adults, the MFI of triple-
cytokine-producing CD4 T cells was significantly greater than the
MFI of single-cytokine producing T cells following in vitro
stimulation with BCG (Figure 6, panel C).
Cytokines and Chemokines in Supernatants
Next we analysed secreted cytokines and chemokines in
supernatants. In accordance with the results from flow cytometry,
there was a significant increase in the concentration of IFN-c, IL-2
and TNF-a after BCG immunisation in both children and adults
(Figures S1 and S2). Comparing the median change (concentra-
tion before BCG immunisation subtracted from concentration
after BCG immunisation) there was no significant difference in the
concentration of Th1 cytokines between children and adults
(Figure 7).
For all other analysed cytokines and chemokines, there were
also no statistically significant differences with the exception of
MIP-1b. This chemokine was significantly more increased in
BCG-immunised adults than in BCG-immunised children follow-
ing in vitro stimulation with BCG (Figure 7).
Interestingly, in both age groups, supernatants from samples
taken before BCG immunisation which were stimulated in vitro
with BCG had increased concentrations of a number of cytokines
(TNF-a, IL-10; IL-6, MCP-1 and MIP-1b) compared to
unstimulated samples (Figures S1 and S2).
Discussion
Investigating differences in the immune response between
children and adults is important to understand the immunological
mechanisms underlying protective efficacy against TB induced by
BCG immunisation. In particular, this may provide an explana-
tion for the difference in protective efficacy afforded by BCG
immunisation in children and adults. Our study is the first to
compare the BCG-induced immune response in children and
adults at the same time interval after immunisation. It is also the
first to analyse the BCG-induced immune response in both age
groups using a comprehensive panel of immunological assays.
The median change in proportions of the seven subpopulations
of Th1 cytokine-producing T cells induced by BCG immunisation
was not different between children and adults. However, in
children a larger number of polyfunctional T cell subsets showed
statistically significant increases in proportions, and these increases
were generally greater. This might be partially explained by the
higher proportions of Th1 cytokine-producing T cells in adults
before immunisation.
A similar spectrum of T cell subpopulations induced by BCG
immunisation was recently reported in a study in infants
immunised at birth in South Africa [16]. The results from this
study are consistent with our finding but the proportions of TNF-
a-single and IFN-c/TNF-a-double cytokine producing cells were
lower in the South African study. This may be attributed to the
lower age of the children in the South African study as the
frequency of TNF-a-producing T cells has been shown to increase
with age [25].
A number of recent studies have investigated polyfunctional
CD4 T cells as potential correlates of protection against TB with
conflicting results. Some studies in TB and human immunodefi-
ciency virus co-infected individuals show an association between
mycobacterial-specific polyfunctional T cells and protection
against TB [26,27,28,29]. In contrast, other studies in humans
suggest that mycobacterial-specific polyfunctional T cells are
associated with active TB disease [30,31]. Also, a case control
study in BCG-immunised infants in South Africa failed to
correlate polyfunctional T cells with protection [10]. Studies
investigating novel TB vaccines in mice, however, have found a
correlation between mycobacterial-specific polyfunctional T cells
(in lung tissue, peripheral blood mononuclear cells or spleen) and
protection [32,33,34,35].
The suggested mechanism underlying the concept that poly-
functional CD4 T cells are key to protection against intracellular
pathogens, including M. tuberculosis, is that the simultaneous
production of IFN-c and TNF-a is synergistic in killing
intracellular pathogens [36] and this effect is further enhanced
by IL-2-induced proliferation of these cells. In addition, polyfunc-
tional CD4 T cells produce greater quantities of each Th1
cytokine compared to single-cytokine-producing cells. Polyfunc-
tional CD4 T cells have been shown to produce more IFN-c,
TNF-a and IL-2 in adults [37,38,39] but, to our knowledge, this is
the first study in children showing that polyfunctional T cells have
higher MFIs and therefore higher cytokine-producing capacity for
all three Th1 cytokines. MFI data must be interpreted cautiously
as they are sometimes based on few cells. However, in our study,
MFI results were only analysed when there were sufficiently high
numbers of CD3 cells.
Relative to the subset of Th1-cytokine-producing CD4 T cells,
the proportion of polyfunctional T cells was greater in children
than in adults. In the studies showing that polyfunctional T cells
are correlates of protection [33,37,40], polyfunctional T cells have
been expressed as a proportion relative to the total number of
CD4 T cells. Therefore, it remains unknown whether the shift to a
more polyfunctional immune response within the Th1-cytokine-
producing cell population observed in children is associated with
better protection. Evaluation of the memory phenotype of T cells
within the Th1-cytokine-producing cell population in future
studies would help discern whether the difference in the
polyfunctional T cell response between children and adults is
attributable to age-related changes in proportions of naı¨ve and
memory phenotypes.
In our study there was no difference between the median
concentrations of Th1-cytokines in supernatants in children and
adults after BCG immunisation. This finding is consistent with the
absence of a difference in the change in proportions of cytokine-
Figure 2. Proportion of cytokine-producing T cells in children before (pre, n=13) and 10 weeks after (post, n =13) BCG
immunisation. Whole blood was incubated for 12 hours with the antigen BCG to measure proportions of IFN-c, IL-2 and TNF-a producing CD4 T
cells (A) and CD8 T cells (C). Boolean analysis was used to calculate proportions of multifunctional cells producing two or all three Th1 cytokines
simultaneously (B, D). Bars indicate medians. Statistical differences with p-values,0.05 are shown. Significant changes after Bonferroni correction are
shown in red.
doi:10.1371/journal.pone.0037535.g002
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Figure 3. Proportion of cytokine-producing T cells in adults before (pre, n=16) and 10 weeks after (post, n =13) BCG immunisation.
Panels A to D as for Figure 2.
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Figure 4. Box plots (with lower quartile, median and upper quartile, whiskers 1.5 IQR) showing median change in the proportion of
cytokine-producing subpopulations of CD4 T cells 10 weeks after BCG immunisation in children (n=13) and adults (n=13). The
proportion of Th1-cytokine-producing subpopulations in CD4 and CD8 T cells was measured following in vitro stimulation with the antigens BCG and
PPD, in whole blood taken before and after BCG immunisation. The median change for (A) CD4 and (B) CD8 T cells was calculated by subtracting
results before BCG immunisation from results after BCG immunisation. Differences were compared using a Mann-Whitney test.
doi:10.1371/journal.pone.0037535.g004
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producing, and in particular polyfunctional CD4 T cells,
measured by flow cytometry. This finding is also in keeping with
a previous study, which did not find a difference in the frequency
of IFN-c-producing T cells and the concentrations of IFN-c, IL-4
and IL-5 in supernatants between children and adults [5].
However, in this study the immune response in adults was
measured several years after BCG immunisation and other factors
including waning of immunity are likely to have influenced the
findings.
The implication of the observed lower MIP-1b induced by BCG
immunisation in children compared to adults is unclear. The role
of MIP-1b in protection against TB is believed to be the
recruitment of monocytes and lymphocytes to the site of infection
and thereby accelerating granuloma formation [41]. MIP-1b has
also been shown to have antimycobacterial properties in macro-
phages [42]. One potential reason for our finding is decreased
MIP-1b production attributable to immaturity of monocytes and
dendritic cells in children.
A number of important in vitro effects of BCG were also
observed in our study. Concentrations of TNF-a, IL-6, IL-10,
MCP-1 and MIP-1b were increased following in vitro stimulation
with BCG in samples from children and adults taken before BCG
immunisation. This finding could be attributed to previous
exposure of the study participants to tuberculous or non-
tuberculous mycobacteria. However, exposure to mycobacteria
in Australia is limited, and moreover all participants over the age
of six months had a negative TST and/or IFN-c release assay
result. It is therefore more likely that the increased concentrations
of these cytokines and chemokines are the result of an in vitro effect
of BCG. This is consistent with evidence from previous studies in
which BCG has been shown to activate monocytes and DCs and
stimulate TNF-a production in vitro [43,44]. This observation is
critically important for the interpretation of results investigating
the immune response to BCG immunisation. Many studies
investigating the immune response to BCG or candidate novel
TB vaccines also use BCG as an antigen for in vitro stimulation.
Thus, effects induced by immunisation may not be distinguishable
from those resulting from in vitro stimulation with BCG. This
finding also underlines one of the strengths of the study reported
here, namely the availability of results from samples taken both
before and after BCG immunisation. The findings also highlight
the importance of the choice of in vitro stimulatory antigen used to
investigate the immune response after BCG immunisation, as
responses to BCG and PPD differed for several cytokines.
The absence of significant differences between children and
adults in almost all the immunological measures in our study
suggests that children in their first year of life and adults have a
comparable immune response induced by BCG. Reported
differences in protective efficacy between children and adults
may therefore be the result of a longer time interval since BCG
immunisation in adults, and consequently waning protection. The
protective efficacy of BCG differs for different manifestations of
TB and is best against severe and disseminated forms that
predominantly affect children under the age of two years (up to
Figure 5. The fraction of single-, double-, and triple- cytokine-producing CD4 T cells relative to the total population of Th1-cytokine
producing cells in children (n=13) and adults (n =13) following in vitro stimulation with antigens (A) BCG and (B) PPD. Differences
were compared using a Mann-Whitney test.
doi:10.1371/journal.pone.0037535.g005
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Figure 6. Fluorescence intensity of CD4 T cells following in vitro stimulation with the antigen BCG. (A) Fluorescence intensity of single-
(yellow), double-(blue), or triple-(red) cytokine-producing CD4 T cells in a representative child 10 weeks after BCG immunisation. Events are plotted
on a logarithmic scale. Cells in the top right hand corner are those producing the greatest amount of both cytokines. (B, C) Median fluorescence
intensity (MFI) for IFN-c-, IL-2- and TNF-a-producing CD4 T cell subpopulations following in vitro stimulation with the antigen BCG for (B) children
(n = 13) and (C) adults (n = 13) 10 weeks after BCG immunisation. White bars show total cytokine-producing populations. Whiskers indicate IQR. Bars
with * are based on one value only. Overall comparison was done using a Kruskal-Wallis test and comparisons of two populations were done using a
Mann-Whitney test. The numbers above the horizontal bars represent the p-values for comparisons. ns = not significant (p.0.05).
doi:10.1371/journal.pone.0037535.g006
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Figure 7. Comparison of the changes in cytokines/chemokines between 13 children (circles) and 13 adults (triangles). Concentrations
were determined using xMAP technology following in vitro stimulation with the antigens BCG and PPD in samples taken before and 10 weeks after
BCG immunisation. Statistical differences were analysed using a using a Mann-Whitney test and p-values ,0.05 are shown. Bars indicate medians.
doi:10.1371/journal.pone.0037535.g007
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73% for TB meningitis and 78% for miliary TB) [1,2]. An
alternative explanation for observed differences in protection
between adults and children could therefore be that BCG provides
better protective efficacy against the disseminated forms of TB that
occur more frequently in infants and young children.
One potential limitation of this study is the multiple statistical
tests done to compare the proportions of cytokine-secreting T cells
and the concentrations of cytokine and chemokines in superna-
tants. The possibility of a statistically significant result arising by
chance was taken into account by Bonferroni corrections. In
addition, the relatively low p-values obtained for many of the
markers investigated make this possibility unlikely. Another
potential limitation is the relatively small sample size and variable
age of the children. However, the assessment of the immune
response in the same study at the same time interval after BCG
immunisation in both children and adults, and the availability of
paired samples (before and after BCG immunisation) are strengths
that allow several interesting and important conclusions.
Our study shows that the cell-mediated mycobacterial-specific
immune response induced by BCG immunisation in children and
adults is comparable. The implication of a shift to a more
polyfunctional immune response within the Th1-cytokine-produc-
ing CD4 T cell population in children is uncertain as this facet of the
mycobacterial-specific immune response has not been assessed as a
potential correlate of protection against TB.
Supporting Information
Figure S1 Concentrations of cytokines and chemokines
in supernatants from children before (grey) and 10
weeks after BCG immunisation. Whole blood of 13 children
was incubated for 7 hours in the presence of the antigens BCG or
PPD. Values for BCG- and PPD-stimulated samples were
corrected by subtracting the concentration in the unstimulated
(NIL) sample. Statistical differences with p-values ,0.05 are
shown in red. Bars indicate medians.
(TIF)
Figure S2 Concentrations of cytokines and chemokines
in supernatants from adults before (grey) and 10 weeks
after BCG immunisation. Whole blood of 13 adults was
incubated for 7 hours in the presence of the antigens BCG or PPD.
Concentrations for BCG- and PPD-stimulated samples were
corrected by subtracting the concentration in the unstimulated
(NIL) sample. Statistical differences with p-values ,0.05 are
shown in red. Bars indicate medians.
(TIF)
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